COMMUNIQUÉS West-GlobeNewswire

Acology Purchases Entire MedTainer Intellectual Property Portfolio
23/04/2018
Purchase Provides Catalysts to Rapid Global Expansion CORONA, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC:ACOL) is pleased to announce the purchase of the entire intellectual property portfolio for [...]
Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares
23/04/2018
MINNEAPOLIS, April 23, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]
Alder BioPharmaceuticals® Appoints Eric Carter, Ph.D., M.D., as Interim Chief Medical Officer
23/04/2018
BOTHELL, Wash., April 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc., (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement
23/04/2018
WESTMINSTER, Colo., April 23, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
HempAmericana Announces Augusta CBD Oil Facility Now “Open for Business”
23/04/2018
NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is thrilled to announce that the new Vitalis R-200 high-capacity supercritical CO2 CBD Oil [...]
Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, [...]
Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales and Marketing Function
23/04/2018
TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility
23/04/2018
EAST RUTHERFORD, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
23/04/2018
First Gene Therapy Using AAV Approach Granted Regenerative Medicine Advanced Therapy Designation NEW YORK and CLEVELAND, April 23, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical- [...]
Achaogen Highlights Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
23/04/2018
-- Study findings support the potential for plazomicin to address difficult-to-treat infections, including those caused by carbapenem-resistant Enterobacteriaceae -- SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE [...]
Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin
23/04/2018
BEVERLY, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a drug supply contract [...]
Prothena Discontinues Development of NEOD001 for AL Amyloidosis
23/04/2018
Phase 2b PRONTO study did not meet its primary or secondary endpoints Phase 3 VITAL Amyloidosis Study being discontinued based on futility analysis Investor conference call and webcast today at 8:30 AM ET DUBLIN, [...]
Beacon Health Selects R1 RCM for Expanded Revenue Cycle Services
23/04/2018
CHICAGO, April 23, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced that Beacon Health based [...]
Sorrento Therapeutics CEO Dr. Henry Ji Invited to the Fourth International Vatican Conference on “Unite to Cure”
23/04/2018
SAN DIEGO, April 23, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, has been invited to participate as an expert panelist at the [...]
Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations
23/04/2018
SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced the appointment of Brad Kreger as Senior Vice President, Global Operations. In this role, Kreger leads [...]
Melinta Therapeutics Presents Results from VABOMERE TANGO II Trial at ECCMID 2018, Highlighting Outcomes in Vulnerable Patient Populations
23/04/2018
NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Fulgent Genetics to Announce First Quarter 2018 Financial Results on Monday May 7, 2018
23/04/2018
TEMPLE CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT ) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2018 financial results after [...]
Lotus Ventures Gets Confirmation of Readiness From Health Canada
23/04/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Health Canada License Update VANCOUVER, British Columbia, April 23, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (“Lotus” or the “ [...]
Catalyst Biosciences Announces Presentation at the 2018 Association for Research in Vision and Ophthalmology Annual Meeting
23/04/2018
SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Pages